» Articles » PMID: 20429882

Concomitant Homozygosity for the Prothrombin Gene Variant with Mild Deficiency of Antithrombin III in a Patient with Multiple Hepatic Infarctions: a Case Report

Overview
Journal J Med Case Rep
Publisher Biomed Central
Specialty General Medicine
Date 2010 May 1
PMID 20429882
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Hereditary causes of visceral thrombosis or thrombosis should be sought among young patients. We present a case of a young man presenting with multiple hepatic infarctions resulting in portal hypertension due to homozygosity of the prothrombin gene mutation not previously described in literature.

Case Presentation: A 42-year-old Caucasian man with a previous history of idiopathic deep vein thrombosis 11 years earlier presented with vague abdominal pains and mildly abnormal liver function tests. An ultrasound and computed tomography scan showed evidence of hepatic infarction and portal hypertension (splenic varices). A thrombophilia screen confirmed a homozygous mutation for the prothrombin gene mutation, with mildly reduced levels of anti-thrombin III (AT III). Subsequent testing of his father and brother revealed heterozygosity for the same gene mutation.

Conclusion: Hepatic infarction is unusual due to the rich dual arterial and venous blood supply to the liver. In the absence of an arterial or haemodynamic insult causing hepatic infarction, a thrombophilia should be considered. To our knowledge, this is the first reported case of a hepatic infarction due to homozygosity of the prothrombin gene mutation. It is unclear whether homozygotes have a higher risk of thrombosis than heterozygotes. In someone presenting with a first thrombosis with this mutation, the case for life-long anticoagulation is unclear, but it may be necessary to prevent a second and more severe second thrombotic event, as occurred in this case.

Citing Articles

Author`s Reply.

Hayiroglu M, Keskin M Anatol J Cardiol. 2017; 17(4):342-343.

PMID: 28466834 PMC: 5469121.


Bilateral renal artery thrombosis in inherited thrombophilia: a rare cause of acute kidney injury.

Wiles K, Hastings L, Muthuppalaniappan V, Hanif M, Abeygunasekara S Int J Nephrol Renovasc Dis. 2014; 7:35-8.

PMID: 24465133 PMC: 3900314. DOI: 10.2147/IJNRD.S50948.

References
1.
Seligsohn U, Lubetsky A . Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16):1222-31. DOI: 10.1056/NEJM200104193441607. View

2.
Souto J, Mateo J, Soria J, Llobet D, COLL I, Borrell M . Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism. Haematologica. 1999; 84(7):627-32. View

3.
Simioni P, Tormene D, Manfrin D, Gavasso S, Luni S, Stocco D . Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. Br J Haematol. 1999; 103(4):1045-50. DOI: 10.1046/j.1365-2141.1998.01112.x. View

4.
Lindmarker P, Schulman S, Sten-Linder M, Wiman B, Egberg N, Johnsson H . The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation. Thromb Haemost. 1999; 81(5):684-9. View

5.
Simioni P, Prandoni P, Lensing A, Manfrin D, Tormene D, Gavasso S . Risk for subsequent venous thromboembolic complications in carriers of the prothrombin or the factor V gene mutation with a first episode of deep-vein thrombosis. Blood. 2000; 96(10):3329-33. View